Standout Papers
Citation Impact
Citing Papers
Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients
2007
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Autophagy in Yeast: ATOR-Mediated Response to Nutrient Starvation
2004 StandoutNobel
An Overview of Autophagy: Morphology, Mechanism, and Regulation
2013 Standout
Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy
2010
Head and neck squamous cell carcinoma
2020 Standout
Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual
2017 Standout
Lifespan extension by calorie restriction relies on the Sty1 MAP kinase stress pathway
2010
Nasopharyngeal carcinoma
2005 Standout
TOR kinase homologs function in a signal transduction pathway that is conserved from yeast to mammals
1999
Expanding global access to radiotherapy
2015 Standout
Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
2011
Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid
2014
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma
2003
Thyroid cancer
2016 Standout
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
2003 StandoutNobel
Matched case–control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report
2005
Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma
2003
Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy
2016
Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up
2015
Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?
2004
Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins
2006
Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets
2002
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
2011 Standout
Individualized treatment in stage IVC nasopharyngeal carcinoma
2014
Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
2010
Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome
2008 Standout
Virulence factors of Candida albicans
2001 Standout
Intensity‐modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma
2006
Treatment of Nasopharyngeal Carcinoma Using Intensity-Modulated Radiotherapy—The National Cancer Centre Singapore Experience
2009
Head and neck cancer
2008 Standout
Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system
2015
Nasopharyngeal carcinoma
2019 Standout
Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapy
2010
Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities
2013
Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing
2004
Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma
2012
Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma
2003
Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation
2005
Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond
2005
Conformity index: A review
2006 Standout
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
2011
Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma
2008
Network organization of the human autophagy system
2010 StandoutNature
Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma
2016
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Preservation of oral health–related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer
2004
Unnecessary laryngeal irradiation in the IMRT era
2004
Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma
2018
Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic group
2004
Clinical use of intensity-modulated radiotherapy: part II
2004
Nasopharyngeal carcinoma
2015 Standout
G‐protein signalling mediates differential production of toxic secondary metabolites
2000
Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma
2019
Induction Chemotherapy with Nedaplatin with 5-FU Followed by Intensity-modulated Radiotherapy Concurrent with Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
2010
Botrytis cinerea : the cause of grey mould disease
2007 Standout
Cancers des voies aérodigestives supérieures : bénéfices cliniques de la radiothérapie conformationnelle et de la modulation d’intensité
2002
Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
2014
Efficacy of targeted FasL in nasopharyngeal carcinoma
2003
Correlation Between Saliva Production and Quality of Life Measurements in Head and Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy
2007
Serine/Threonine Protein Kinases and Phosphatases in Filamentious Fungi
1999
Epstein–Barr virus: 40 years on
2004 Standout
Preservation of quality of life after intensity‐modulated radiotherapy for early‐stage nasopharyngeal carcinoma: Results of a prospective longitudinal study
2006
The battle against nasopharyngeal cancer
2012
Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
2004
Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era
2014
The Top 10 fungal pathogens in molecular plant pathology
2012 Standout
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
2007 Standout
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial
2006
New Radiation Therapy Techniques for the Treatment of Head and Neck Cancer
2005
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers
2006
Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy
2004
A Phase III Study of Late Course Accelerated Hyperfractionated Radiotherapy Versus Conventionally Fractionated Radiotherapy in Patients With Nasopharyngeal Carcinoma
2011
Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma
2015
Cyclophilin A and calcineurin functions investigated by gene inactivation, cyclosporin A inhibition and cDNA arrays approaches in the phytopathogenic fungusBotrytis cinerea
2003
Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines
2013 Standout
Physiological Roles of Mitochondrial Reactive Oxygen Species
2012 Standout
MAP Kinases in Fungal Pathogens
2000
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma
2012
Analysis of expressed sequence tags from Gibberella zeae (anamorph Fusarium graminearum)
2003
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
2012
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Clinical use of intensity-modulated radiotherapy: part I
2004
Fungal secondary metabolism — from biochemistry to genomics
2005 Standout
New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system
2015
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Intensity‐modulated radiotherapy for early‐stage nasopharyngeal carcinoma
2004
Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors
2014
Quality of Life and Survival Outcome for Patients With Nasopharyngeal Carcinoma Receiving Three-Dimensional Conformal Radiotherapy vs. Intensity-Modulated Radiotherapy—A Longitudinal Study
2008
Salvage gemcitabine–vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
2012
Molecular mechanisms of mTOR-mediated translational control
2009 Standout
Heading for disaster: Fusarium graminearum on cereal crops
2004 Standout
Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis
2015
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial
2016
Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety
2005
An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma
2013
Head and Neck Cancer
2020 Standout
Anaplastic thyroid cancer
2013
Genetic Involvement of a cAMP-Dependent Protein Kinase in a G Protein Signaling Pathway Regulating Morphological and Chemical Transitions in Aspergillus nidulans
2001
Signal Transduction Cascades Regulating Fungal Development and Virulence
2000
Proposed modifications and incorporation of plasma Epstein‐Barr virus DNA improve the TNM staging system for Epstein‐Barr virus‐related nasopharyngeal carcinoma
2018
Regulation Mechanisms and Signaling Pathways of Autophagy
2009 Standout
Evidence on effectiveness of intensity‐modulated radiotherapy versus 2‐dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta‐analysis and a systematic review of the literature
2014
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
2015
Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: A SEER-Medicare analysis
2012
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Relationship between Secondary Metabolism and Fungal Development
2002
Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma
2006
Morbidities after maxillary swing nasopharyngectomy for recurrent nasopharyngeal carcinoma
2014
Cyclic AMP-Dependent Protein Kinase Controls Virulence of the Fungal Pathogen Cryptococcus neoformans
2001
Guidelines for the management of thyroid cancer
2014 Standout
Antagonistic Controls of Autophagy and Glycogen Accumulation by Snf1p, the Yeast Homolog of AMP-Activated Protein Kinase, and the Cyclin-Dependent Kinase Pho85p
2001
Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma
2013
Galleria mellonella as a Model System To Study Cryptococcus neoformans Pathogenesis
2005 Standout
Long‐term outcomes after reirradiation in nasopharyngeal carcinoma with intensity‐modulated radiotherapy: A meta‐analysis
2017
Works of Nancy Lee being referenced
Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literature
2010
Hypofractionated Dose-Painting Intensity Modulated Radiation Therapy With Chemotherapy for Nasopharyngeal Carcinoma: A Prospective Trial
2010
Geometric factors influencing dosimetric sparing of the parotid glands using IMRT
2006
Signaling via cAMP in fungi: interconnections with mitogen-activated protein kinase pathways
1998
Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation
2003
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Intensity-Modulated Radiation Therapy in Head and Neck Cancers
2005
Intensity‐modulated radiation therapy in head and neck cancers: An update
2005
A forward-planned treatment technique using multisegments in the treatment of head-and-neck cancer
2004
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225
2009
Intensity-Modulated Radiation Therapy for Head and Neck Carcinoma
2007